Phase 1b Study to Evaluate Safety, Tolerability, and Maximum Tolerated Dose of PF-05230907 for Intracerebral Hemorrhage

Yolanda Silva Blas, Michael N. Diringer, Benjamin Lo, Jaime Masjuan, Natalia Pérez De La Ossa, Matthew Cardinal, Florence Yong, Tong Zhu, Gang Li, Steven Arkin

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Phase 1b Study to Evaluate Safety, Tolerability, and Maximum Tolerated Dose of PF-05230907 for Intracerebral Hemorrhage'. Together they form a unique fingerprint.

Medicine & Life Sciences